These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6840159)

  • 21. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the antihypertensive effect and some pharmacodynamic aspects of nifedipine in medium-term treatment.
    Masotti G; Poggesi L; Castellani S; Morettini A; Galanti G; Scarti L
    Int J Clin Pharmacol Res; 1984; 4(1):71-9. PubMed ID: 6469434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-pharmacologic study on the liquid form of nifedipine in treating hypertensive crisis].
    Popiliev I; Angelova I; Dzhoneva S; Khodzheva D
    Vutr Boles; 1989; 28(1):22-6. PubMed ID: 2741437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.
    Challenor V; Waller DG; Gruchy BS; Renwick AG; George CF; McMurdo ET; McEwen J
    Br J Clin Pharmacol; 1986 Nov; 22(5):565-70. PubMed ID: 3790403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?
    Toal CB
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of slow release nifedipine tablets in patients with essential hypertension.
    Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H
    Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.
    Ishii H; Itoh K; Nose T
    Eur J Pharmacol; 1980 May; 64(1):21-9. PubMed ID: 7449813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benidipine hydrochloride--a new calcium-channel blocker of the dihydropyridine type. Pharmacokinetics, pharmacodynamics, tolerance and dose finding in mild to moderate hypertension.
    Maier-Lenz H; Rode H; Lenau H; Thieme G; Wölke E; Kobayashi H; Kobayashi S; Oka T
    Arzneimittelforschung; 1988 Nov; 38(11A):1757-63. PubMed ID: 3219156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: a randomised crossover study.
    Cappuccio FP; Markandu ND; Tucker FA; MacGregor GA
    Eur J Clin Pharmacol; 1986; 30(6):723-5. PubMed ID: 3533567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antihypertensive effect of orally administered nifedipine-loaded nanoparticles in spontaneously hypertensive rats.
    Kim YI; Fluckiger L; Hoffman M; Lartaud-Idjouadiene I; Atkinson J; Maincent P
    Br J Pharmacol; 1997 Feb; 120(3):399-404. PubMed ID: 9031742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients.
    Kleinbloesem CH; van Brummelen P; Faber H; Breimer DD
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):202-8. PubMed ID: 2435999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between the hypotensive effect of increasing single doses of nifedipine tablets with its plasma concentration in patients with essential hypertension.
    Streifler JY; Zyber-Katz E; Rosenfeld JB
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):657-61. PubMed ID: 3912333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive and hormonal effects of single oral doses of captopril and nifedipine in essential hypertension.
    Soto ME; Thibonnier M; Sire O; Menard J; Corvol P; Milliez P
    Eur J Clin Pharmacol; 1981; 20(3):157-61. PubMed ID: 7026255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of different oral nifedipine preparations in healthy Brazilian volunteers.
    Vianna-Jorge R; Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1992; 25(4):385-91. PubMed ID: 1342215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S; Rietbrock S; Thürmann P
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute antihypertensive effect of nifedipine by sublingual route in cases with clinically severe systolic hypertension. A study up to 4 h after administration.
    Ito H; Arakawa M; Shibasaki T; Hirakawa S; Fukuda T; Yasue T; Kondo Y; Watanabe I; Mori N; Fueki T
    Arzneimittelforschung; 1984; 34(5):630-6. PubMed ID: 6380506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration.
    Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.